GRP78 via releasing β-catenin from adherens junctions facilitates its interaction with STAT3 in mediating retinal neovascularization

Raj Kumar,Gadiparthi N Rao
DOI: https://doi.org/10.1016/j.ajpath.2024.08.005
2024-08-31
Abstract:Retinopathy due neovascularization is one of the major causes of vision loss. To understand the mechanisms underlying retinal neovascularization, using oxygen-induced retinopathy (OIR) model, we performed 2D gel-MALDI-TOF/TOF analysis of normoxic and 24-h post OIR mice pups' retinas. 2D gel analysis revealed that GRP78 is one of the several molecules induced by OIR in the retinal ECs. VEGFA also induced GRP78 expression independent of ER stress response in HRMVECs and depletion of its levels reduced VEGFA-induced EC angiogenic responses. Consistent with these observations, EC-specific deletion of GRP78 inhibited OIR-induced retinal neovascularization. In exploring the mechanisms, we found that GRP78 binds with VE-cadherin and releases adherens junction's but not Wnt-mediated β-catenin and that β-catenin, in turn, via interacting with STAT3 triggers cyclin D1 expression. Furthermore, depletion of β-catenin or cyclin D1 levels negated VEGFA-induced EC angiogenic responses and OIR-induced retinal neovascularization. EC-specific deletion of GRP78 also suppressed OIR-induced vascular leakage. In elucidating the upstream signaling, we found that ATF6 mediates GRP78 induction in the modulation of VEGFA-induced EC angiogenic responses and OIR-induced retinal neovascularization. Together, these observations reveal that GRP78 independent of its response to ER stress is involved in mediating EC angiogenic responses by VEGFA and retinal neovascularization by OIR. In view of these findings, it appears that GRP78 could be a desirable target for drug development against diabetic retinopathy.
What problem does this paper attempt to address?